Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of melanoma development in the Nras(Q61K)::Ink4a−/− mouse model by the small molecule BI‐69A11
Yongmei Feng, Eric Lau, Marzia Scortegagna, et al.
Pigment Cell & Melanoma Research (2012) Vol. 26, Iss. 1, pp. 136-142
Open Access | Times Cited: 19

Showing 19 citing articles:

Treatment of NRAS-Mutant Melanoma
Douglas B. Johnson, Igor Puzanov
Current Treatment Options in Oncology (2015) Vol. 16, Iss. 4
Open Access | Times Cited: 127
Mechanisms of Drug Resistance in Melanoma
Matthew L. Winder, Amaya Virós
Handbook of experimental pharmacology (2017), pp. 91-108
Closed Access | Times Cited: 90
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Fei Du, Lu-han Yang, Jiao Liu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Synthesis, Characterization and Anti-Cancer Activity of Hydrazide Derivatives Incorporating a Quinoline Moiety
Murat Bingül, Owen Tan, Christopher R. Gardner, et al.
Molecules (2016) Vol. 21, Iss. 7, pp. 916-916
Open Access | Times Cited: 71
Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors
Riham F. George, Eman M. Samir, Mennatullah N. Abdelhamed, et al.
Bioorganic Chemistry (2018) Vol. 83, pp. 186-197
Closed Access | Times Cited: 67
Molecular Pathways: Targeting NRAS in Melanoma and Acute Myelogenous Leukemia
Douglas B. Johnson, Keiran S.M. Smalley, Jeffrey A. Sosman
Clinical Cancer Research (2014) Vol. 20, Iss. 16, pp. 4186-4192
Open Access | Times Cited: 64
Exploration of novel quinoline derivatives: Anticancer potential revealed through design, synthesis and biological evaluation
Janaiah Chevula, Saikrishna Balabadra, Ramakrishna Munnaluri, et al.
Journal of Chemical Sciences (2025) Vol. 137, Iss. 2
Closed Access
DNA targeting half sandwich Ru(ii)-p-cymene-N^N complexes as cancer cell imaging and terminating agents: influence of regioisomers in cytotoxicity
Ashaparna Mondal, Utsav Sen, Nilmadhab Roy, et al.
Dalton Transactions (2020) Vol. 50, Iss. 3, pp. 979-997
Closed Access | Times Cited: 35
SBI-0640756 Attenuates the Growth of Clinically Unresponsive Melanomas by Disrupting the eIF4F Translation Initiation Complex
Yongmei Feng, Anthony B. Pinkerton, Laura Hulea, et al.
Cancer Research (2015) Vol. 75, Iss. 24, pp. 5211-5218
Open Access | Times Cited: 35
Mitochondrial function in melanoma
Nicholas Theodosakis, Goran Micevic, Daniel P. Kelly, et al.
Archives of Biochemistry and Biophysics (2014) Vol. 563, pp. 56-59
Closed Access | Times Cited: 27
Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition
Andrew C. McShan, David Flores‐Solis, Yi Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Synthesis and SAR Studies of Dual AKT/NF‐κB Inhibitors Against Melanoma
Elisa Barile, Surya K. De, Yongmei Feng, et al.
Chemical Biology & Drug Design (2013) Vol. 82, Iss. 5, pp. 520-533
Open Access | Times Cited: 20
NRAS Mutant Melanoma: An Overview for the Clinician for Melanoma Management
Russell W. Jenkins, Ryan J. Sullivan
Melanoma Management (2016) Vol. 3, Iss. 1, pp. 47-59
Open Access | Times Cited: 16
Searching for the Chokehold of NRAS Mutant Melanoma
Christian Posch, Igor Vujic, Babak Itzinger-Monshi, et al.
Journal of Investigative Dermatology (2016) Vol. 136, Iss. 7, pp. 1330-1336
Open Access | Times Cited: 16
Synthesis, characterization and anticancer activity of novel ferrocene containing quinolinones: 1-Allyl-2-ferrocenyl-2,3-dihydroquinolin-4(1H)-ones and 1-allyl-2-ferrocenylquinolin-4(1H)-ones
Anka Pejović, J. Drabowicz, Marcin Cieślak, et al.
Journal of Organometallic Chemistry (2018) Vol. 873, pp. 78-85
Closed Access | Times Cited: 8
Synthesis of 1-[(Aryl)(3-amino-5-oxopyrazolidin-4-ylidene) methyl]-2-oxo-1,2-dihydroquinoline-3-carboxylic Acid Derivatives and Their Breast Anticancer Activity
Ahmed Gaber, Walaa F. Alsanie, Majid Alhomrani, et al.
Crystals (2021) Vol. 11, Iss. 5, pp. 571-571
Open Access | Times Cited: 6
Synthesis and Transformations of 4-Hydroxy-2-methylquinoline-6-carbohydrazide
I. L. Aleksanyan, L. P. Hambardzumyan
Russian Journal of Organic Chemistry (2019) Vol. 55, Iss. 2, pp. 262-265
Closed Access | Times Cited: 5
ANTIMICROBIAL ACTIVITY OF QUINOLINE-BASED HYDROXYPHENYLAMINO AND CARBOXYPHENYLAMINO DERIVATIVES
L. P. Hambardzumyan, Iskuhi L. Aleksanyan
Proceedings of the YSU B Chemical and Biological Sciences (2023) Vol. 57, Iss. 3 (262), pp. 301-312
Open Access
Syntheses Based on 4-(2-Hydroxy-4-methylquinolin-3-yl)butan-2-one Thiosemicarbazones
I. L. Aleksanyan, L. P. Hambardzumyan
Russian Journal of Organic Chemistry (2019) Vol. 55, Iss. 3, pp. 399-401
Closed Access
Melanoma (Skin Cancer)
Surya K. De
(2022), pp. 285-303
Closed Access
Page 1

Scroll to top